519
Views
11
CrossRef citations to date
0
Altmetric
Letter to the Editor

Lymphocytic variant hypereosinophilic syndrome progressing to angioimmunoblastic T-cell lymphoma

, , &
Pages 1891-1894 | Received 19 Sep 2014, Accepted 09 Oct 2014, Published online: 19 Nov 2014

References

  • Roufosse F, Cogan E, Goldman M. Lymphocytic variant hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007; 27:389–413.
  • Gleich GJ, Schroeter AL, Marcoux JP, et al. Episodic angioedema associated with eosinophilia. N Engl J Med 1984;310:1621–1626.
  • Roufosse F, de Lavareille A, Schandene L, et al. Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome. J Allergy Clin Immunol 2010;126:828–835 e3.
  • Chu VT, Frohlich A, Steinhauser G, et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol 2011;12:151–159.
  • Jacobsen EA, Ochkur SI, Pero RS, et al. Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med 2008;205:699–710.
  • Ravoet M, Sibille C, Roufosse F, et al. 6q- is an early and persistent chromosomal aberration in CD3-CD4 + T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome. Haematologica 2005;90:753–765.
  • de Leval L, Rickman DS, Thielen C, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007;109:4952–4963.
  • Roufosse F, Garaud S, de Leval L. Lymphoproliferative disorders associated with hypereosinophilia. Semin Hematol 2012; 49:138–148.
  • Attygalle AD, Kyriakou C, Dupuis J, et al. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol 2007;31:1077–1088.
  • Ravoet M, Sibille C, Gu C, et al. Molecular profiling of CD3-CD4 + T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways. Blood 2009; 114:2969–2983.
  • Thielen C, Radermacher V, Trimeche M, et al. TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas. Leuk Res 2008;32:1431–1438.
  • McKelvie P, Oon S, Romas E, et al. A case of systemic anaplastic lymphoma kinase-negative anaplastic large cell lymphoma associated with hypereosinophilia, granulomatous myositis and vasculitis. Leuk Lymphoma 2012;53:2279–2282.
  • Harfi I, Schandene L, Dremier S, et al. Eosinophils affect functions of in vitro-activated human CD3-CD4 + T cells. J Transl Med 2013;11:112.
  • Roufosse FE, Kahn JE, Gleich GJ, et al. Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes. J Allergy Clin Immunol 2013;131:461–467 e1-5.
  • Gleich GJ, Klion AD, Lee JJ, et al. The consequences of not having eosinophils. Allergy 2013;68:829–835.
  • Klion AD, Mejia R, Cowen EW, et al. Chronic active Epstein-Barr virus infection:a novel cause of lymphocytic variant hypereosinophilic syndrome. Blood 2013;121:2364–2366.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.